{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:55:49Z","timestamp":1791143749055,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.physbeh.2011.04.055","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T00:31:55Z","timestamp":1304814715000},"page":"168-172","source":"Crossref","is-referenced-by-count":67,"title":["Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease"],"prefix":"10.1016","volume":"104","author":[{"given":"J. Eric","family":"Ahlskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.physbeh.2011.04.055_bb0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-003-0027-5","article-title":"Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum","volume":"110","author":"Gerlach","year":"2003","journal-title":"J Neural Transm"},{"issue":"6289","key":"10.1016\/j.physbeh.2011.04.055_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.physbeh.2011.04.055_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.physbeh.2011.04.055_bb0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1212\/01.WNL.0000076478.45005.EC","article-title":"Pathological gambling associated with dopamine agonist therapy in Parkinson's disease","volume":"61","author":"Driver-Dunckley","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.physbeh.2011.04.055_bb0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.physbeh.2011.04.055_bb0030","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/mds.21611","article-title":"Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series","volume":"22","author":"Gallagher","year":"2007","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.physbeh.2011.04.055_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.physbeh.2011.04.055_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.parkreldis.2007.04.004","article-title":"Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"13","author":"McKeon","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","article-title":"Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies","volume":"17","author":"Hassan","year":"2011","journal-title":"Parkinsonism Relat Disord."},{"issue":"8","key":"10.1016\/j.physbeh.2011.04.055_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","article-title":"Medication-related impulse control and repetitive behaviors in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.physbeh.2011.04.055_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4065\/84.4.310","article-title":"Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease","volume":"84","author":"Bostwick","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.physbeh.2011.04.055_bb0070","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.physbeh.2011.04.055_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.physbeh.2011.04.055_bb0080","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"A randomized controlled trial comparing the agonist pramipexole with levodopa as initial dopaminergic treatment for Parkinson's disease","volume":"284","author":"Parkinson-Study-Group","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.physbeh.2011.04.055_bb0085","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneur.61.7.1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial","volume":"61","author":"Holloway","year":"2004","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.physbeh.2011.04.055_bb0090","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.22902","article-title":"Impulsive\u2013compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy","volume":"25","author":"O'Sullivan","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.physbeh.2011.04.055_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","article-title":"Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome","volume":"30","author":"Driver-Dunckley","year":"2007","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.wnl.0000252368.25106.b6","article-title":"Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists","volume":"68","author":"Tippmann-Peikert","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.physbeh.2011.04.055_bb0105","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2006.10.001","article-title":"Pathological gambling associated with dopamine agonist use in restless legs syndrome","volume":"13","author":"Quickfall","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"10.1016\/j.physbeh.2011.04.055_bb0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2009.11.010","article-title":"Compulsive habits in restless legs syndrome patients under dopaminergic treatment","volume":"290","author":"Pourcher","year":"2010","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.physbeh.2011.04.055_bb0115","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.neuropsych.19.4.473","article-title":"Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma","volume":"19","author":"Davie","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.physbeh.2011.04.055_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5694\/j.1326-5377.2009.tb02289.x","article-title":"Pathological gambling and hypersexuality in cabergoline-treated prolactinoma","volume":"190","author":"Falhammar","year":"2009","journal-title":"Med J Aust"},{"issue":"12","key":"10.1016\/j.physbeh.2011.04.055_bb0130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2007.01.009","article-title":"Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists","volume":"14","author":"Singh","year":"2007","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.physbeh.2011.04.055_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in parkinson disease: a multicenter case\u2013control study","author":"Voon","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.physbeh.2011.04.055_bb0140","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","article-title":"Prospective prevalence of pathologic gambling and medication association in Parkinson disease","volume":"66","author":"Voon","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.physbeh.2011.04.055_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WNF.0b013e3181684542","article-title":"Impulse control disorders arising in 3 patients treated with rotigotine","volume":"32","author":"Wingo","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.physbeh.2011.04.055_bb0150","doi-asserted-by":"crossref","unstructured":"Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol. Jan;67(1):58\u201363.","DOI":"10.1001\/archneurol.2009.294"},{"issue":"Pt 5","key":"10.1016\/j.physbeh.2011.04.055_bb0155","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain"},{"issue":"Pt 4","key":"10.1016\/j.physbeh.2011.04.055_bb0160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","article-title":"Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive\u2013compulsive behaviours","volume":"134","author":"O'Sullivan","year":"2011","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.physbeh.2011.04.055_bb0165","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/mds.23369","article-title":"Parkinson's disease and pathological gambling: results from a functional MRI study","volume":"25","author":"Frosini","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.physbeh.2011.04.055_bb0170","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hbm.21067","article-title":"Pramipexole modulates the neural network of reward anticipation","volume":"32","author":"Ye","year":"2010","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"10.1016\/j.physbeh.2011.04.055_bb0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/archneur.64.2.212","article-title":"Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease","volume":"64","author":"Voon","year":"2007","journal-title":"Arch Neurol"},{"issue":"13","key":"10.1016\/j.physbeh.2011.04.055_bb0180","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/mds.23247","article-title":"Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease","volume":"25","author":"Djamshidian","year":"2010","journal-title":"Mov Disord."},{"issue":"1","key":"10.1016\/j.physbeh.2011.04.055_bb0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuron.2009.12.027","article-title":"Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors","volume":"65","author":"Voon","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.physbeh.2011.04.055_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0269881109358201","article-title":"PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats","volume":"25","author":"Higley","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.physbeh.2011.04.055_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S1461145709991064","article-title":"The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking","volume":"13","author":"Khaled","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0200","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.neuropharm.2008.12.007","article-title":"The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats","volume":"56","author":"Peng","year":"2009","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.physbeh.2011.04.055_bb0205","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S1461145709990642","article-title":"Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925","volume":"13","author":"Graff-Guerrero","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.physbeh.2011.04.055_bb0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.biopsych.2010.04.038","article-title":"Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist","volume":"68","author":"Searle","year":"2010","journal-title":"Biol Psychiatry"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938411002149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938411002149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:03:46Z","timestamp":1592525026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938411002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0031938411002149"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2011.04.055","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}